(r)-3-hydroxybutanoic acid

(r)-3-hydroxybutanoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2725 references associated with (r)-3-hydroxybutanoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for (r)-3-hydroxybutanoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (r)-3-hydroxybutanoic acid

MeSH term MeSH ID Detail
Spasms, Infantile D013036 3 associated lipids
Insulin Coma D007331 2 associated lipids
Congenital Hyperinsulinism D044903 1 associated lipids
Septo-Optic Dysplasia D025962 1 associated lipids
Lethargy D053609 1 associated lipids
Forearm Injuries D005543 1 associated lipids
Median Neuropathy D020423 1 associated lipids
Ulnar Neuropathies D020424 1 associated lipids
Wrist Injuries D014954 1 associated lipids
Genomic Instability D042822 7 associated lipids
Per page 10 20 50 100 | Total 185

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with (r)-3-hydroxybutanoic acid

Download all related citations
Per page 10 20 50 100 | Total 2707
Authors Title Published Journal PubMed Link
Møller N et al. Lack of effects of hyperglycemia on the disposal of 3-hydroxybutyrate in insulin-dependent diabetic patients. 1990 Acta Endocrinol. pmid:2284887
Hermansen K et al. Diurnal plasma profiles of metabolite and hormone concentration in insulin-dependent diabetic patients during conventional insulin treatment and continuous subcutaneous insulin infusion. A controlled study. 1987 Acta Endocrinol. pmid:3551432
De Pergola G et al. D-(-)-beta-hydroxybutyrate inhibits catecholamine-stimulated lipolysis and decreases beta-adrenoceptors' affinity in human fat cells but not in lymphomonocytes. 1990 Acta Endocrinol. pmid:2159203
Subekti I Post-prandial hyperglycemia in type 2 diabetes mellitus, diabetic cornea neuropathy and beta hydroxyl butyrate in diabetic ketoacidosis. 2004 Jul-Sep Acta Med Indones pmid:15568228
Gustaviani R et al. The influence of calorie restriction during the Ramadan fast on serum fructosamine and the formation of beta hydroxybutirate in type 2 diabetes mellitus patients. 2004 Jul-Sep Acta Med Indones pmid:15557682
Wijaya IP et al. Beta-hydroxybutirate levels as a determinant for the success of diabetic ketoacidosis management. 2004 Apr-Jun Acta Med Indones pmid:15673940
Biswas A et al. Production of poly-3-hydroxyalkanoic acids by a moderately halophilic bacterium, Halomonas marina HMA 103 isolated from solar saltern of Orissa, India. 2009 Acta Microbiol Immunol Hung pmid:19621765
Melegh B et al. Uptake of beta-hydroxybutyrate, acetoacetate and glucose by the forearm of the newborn infant. 1986 Acta Paediatr Hung pmid:3593582
Cederblad G et al. Carnitine in maternal and neonatal plasma. 1985 Acta Paediatr Scand pmid:4024920
Swanström S and Bratteby LE Metabolic effects of obstetric regional analgesia and of asphyxia in the newborn infant during the first two hours after birth. II. Arterial plasma concentrations of glycerol, free fatty acids and beta-hydroxybutyrate. 1981 Acta Paediatr Scand pmid:7324934